Assistance Publique - Hôpitaux de Paris: Lymphoma trials

The registry lists 18 Lymphoma studies with Assistance Publique - Hôpitaux de Paris as lead sponsor. 6 are open to participants now and 0 have results posted.

Phase 1 2Phase 2 2Phase 3 1No phase 14(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Study of the Association Between Fatigue Experienced by Patients and the Specific Side Effects of CART Cells, During the First Month After Administration for Non-Hodgkin's LymphomaNot yet recruitingNCT06890091
• Virus-associated Tumour MicroenvironmentRecruitingNCT06471296
• Incidence and Risks Factors of CMV Reactivation in Patients Receiving of CAR-T Cells for Acute Leukemia and Lymphoma Relapse, a Cohort Study AnalysisRecruitingNCT06058858
• Clonal Hematopoiesis of Immunological SignificanceNot yet recruitingNCT05969821
• Dose Dense Re-challenge of High Dose Methotrexate With Glucarpidase for Relapsed Primary Central Nervous System LymphomaRecruitingNCT05135858Phase 1
• Identification of Prognostic Factors and New Therapeutic Targets in Cutaneous LymphomasNot yet recruitingNCT04520529Not applicable
• Clinico-biological Characterization and Survival of Patients With Adult T-cell Leukemia / Lymphoma (ATL) and Patients Chronically Infected With the HTLV-1 Virus (HTLV-OBS)Active, not recruitingNCT05237245
• Early Detection of Patients at Risk of Developing Anthracycline Cardiotoxicity With TEP/CT -FDGActive, not recruitingNCT04892667Not applicable
• Evaluation of Long-term Health Status and Quality of Life in Adult Survivors With Philadelphia-negative Acute Lymphoblastic Leukemia/Lymphoma Treated With an Intensive Pediatric or Pediatric-inspired ProtocolStatus unknownNCT04677231
• Mathematic Modeling at Micro and Macroscopic Level of Primary Central Nervous System Lymphomas (PCNSL)Status unknownNCT04253496
• A Study Evaluating the Safety of Cal-1 (LVsh5/C46) Drug Product in HIV-1 Infected Patient With High Risk LymphomaCompletedNCT03593187Phase 1/2
• Role of [18F]-FDG Brain PET in Newly Diagnosed Primary Cerebral Lymphoma, in Immunocompetent Patient Older Than 60 YearsStatus unknownNCT03582254Not applicable
• Benefit of Allogeneic Haematopoietic Stem Cells in Cutaneous T-cell Lymphomas Epidermotropic With Advanced Stage and Poor PrognosisActive, not recruitingNCT02520908
• Maintenance Treatment Versus Observation in Elderly Patients With PCNS LymphomaStatus unknownNCT02313389Phase 3
• Coproporphyrine Isomers and Methotrexate EliminationCompletedNCT00822432
• Killer Immunoglobulin-Like Receptor Transcripts Expression for the Diagnosis of Epidermotropic Cutaneous T Cell LymphomaCompletedNCT00748319Not applicable
• Methotrexate and Temozolomide Versus Methotrexate, Procarbazine, Vincristine and CytarabineStatus unknownNCT00503594Phase 2
• The RATIO: Registry of Infections and Lymphoma in Patients Treated With TNF-a AntagonistsStatus unknownNCT00224562